The epidemiology of bacterial meningitis has changed as a result of the widespread use of
conjugate vaccines and preventive antimicrobial treatment of pregnant women. Given the …

AGA technical review on perianal Crohn’s disease - ScienceDirect Skip to main contentSkip to
article Elsevier logo Journals & Books Search RegisterSign in View PDF Download full issue …

The relationship between the use of tumor necrosis factor antagonists and onset of
granulomatous infection was examined using data collected through the Adverse Event …

Background & Aims: The aim of this study was to evaluate the short-and long-term safety of
infliximab in patients with Crohn's disease in clinical practice. Methods: The medical records …

Rheumatoid arthritis affects about 1 percent of the US population and can cause irreversible
joint deformities and functional impairment. Although the cause of this autoimmune disease …

Introduction: TNF-α is a pro-inflammatory cytokine known to a have a key role in the
pathogenesis of chronic immune-mediated diseases. TNF-α inhibitors can be administered …

Objective Tumor necrosis factor α (TNFα) has been implicated in the pathogenesis of certain
inflammatory diseases. Two TNFα‐neutralizing agents are licensed in the US. Infliximab is …

Purpose. Current and investigational treatments of rheumatoid arthritis (RA) are described.
Summary. The current therapies used to treat RA include nonsteroidal antiinflammatory …

OBJECTIVE: Tumor necrosis factor (TNF) antagonists fall into 2 classes: etanercept (ETA) is
a soluble TNF receptor, while infliximab (INF) and adalimumab (ADA) are monoclonal …

Induction therapy with infliximab is indicated for treatment of signs and symptoms, and
induction and maintenance of remission in patients with moderate to severely active …